Exelixis



Ebit Changement Date
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Amgen USD 2.26B 1.34B 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Bayer EUR -36000000 2.95B 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
Eisai JPY 20.74B 1.77B 2025-06
Eli Lilly USD 7.02B 3.32B 2025-06
Exelixis USD 215.68M 28.82M 2025-07
Genmab DKK 432M 900.27M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 310.82M 27.18M 2025-06
Ionis Pharmaceuticals USD 144.78M 290.78M 2025-06
MacroGenics USD -52837000 107.35M 2024-12
Merck USD 6.36B 149M 2025-06
Moderna USD -817000000 146M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Sanofi EUR 2.22B 2.84B 2024-12
Takeda JPY 257.79B 387.52B 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Xencor USD -22832000 16.77M 2025-06


Exelixis - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.